Cytokine profile in graft-versus-host disease after small bowel transplantation by Galvao, FHF et al.
Cytokine Profile in Graft-Versus-Host Disease After Small 
Bowel Transplantation 
F.H.F. Galvao, N. Murase, S. Todo, A. Zeevi, Q. Ye, C.S. Daughton, A.J. Demetris, D.L. Waitzberg, 
J.J. Fung, and T.E. Starzl 
GRAFf-versus-host disease (GVHD) remains a prob-lematic immune reaction and has been a major 
concern after the transplantation of lymphoid-rich tissues, 
such as the small bowel. We recently developed a novel 
experimental animal model of GVHD.1 This study de-
scribes the histopathologic changes and cytokine profiles of 
these animals before and after the onset of clinical signs of 
GVHD. 
MATERIALS AND METHODS 
Male ACI (Rna) and Lewis (LEW. Rnl) rats were used as donors 
and recipients. respectively. Simultaneous orthotopic small bowel 
transplantation (portocaval drainage) with bone marrow (2.5 X lOS 
unfractionated cells) infusion was perfonned under immunosup-
pression of intramuscular FK 506 1.0 mglkgld for 2 weeks (day 0 to 
13), followed by a weekly injection of the same dose thereafter. All 
recipients developed clinical signs of GVHD (skin rash. pile loss. 
and hyperkeratosis) between 98 and 107 days after transplantation. 
Recipients were sacrificed after clinical manifestation of GVHD 
(120 days after transplantation. group 1. n = 3) or prior to any 
overt sign of GVHD (65 days after transplantation. group 2. n = 3). 
Controls comprised FK 506 treated Lewis recipients of isografts. 
sacrificed either 120 days (group 3. n = 3) or 65 days (group 4. n = 
3) after transplantation. At the time of sacrifice. the cervical lymph 
nodes (CLN). tongue (TO). graft (GSB), and recipient small bowel 
(RSB) were harvested for histopathologic examination and semi-
quantitative cytokine analysis by reverse transcription polymerase 
chain reaction (RT-PCR) using 32p terminally labeled primer for 
interleukin (IL)-2. IL-4. IL-I0. and interferon (IFN)_y.2 f3-actin 
level in each sample was assessed for internal quality control and 
results were expressed as a ratio of cytokine/f3-actin mRNA. 
RESULTS 
Isografted recIpients did not show any histopathologic 
changes in any sample analyzed. The CLN and TG in group 
1 animals showed typical changes of grade II GVHD 
according to the criteria detailed by Markus et al.3 All 
animals from group 2 presented with grade I GVHD in the 
CLN and TG. GSB in these animals were essentially 
normal. No abnormality was observed in the RSB. 
IL-2 and IL-4 mRNA levels were not increased in any 
samples. Before the onset of GVHD, levels of IFN-y 
mRNA. compared with respective isograft controls, were 
upregulated in the TG (0.66 :!: 0.30% vs 0%, P < .05) and 
CLN (0.30 :!: 0.10% vs 0.01%, P < .05). mRNA for IL-IO 
increased in the CLN (0.67 :!: 0.21% vs 0.01 %. P < .005). 
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After the onset of GVHD, IFN-'Y were upregulated in the 
TG (0.70 :!: 0.29% vs 0%, P < .01) and CLN (0.38 :!: 0.18% 
vs 0.01%, P < .03). IL-I0 mRNA increased in the TG 
(0.84 :!: 0.20% vs 0.01 %, P < .002) and CLN (0.64 :!: 0.05% 
vs 0.01%, P < .00(1). GSB and RSB did not show any 
increased expression of these cytokines. 
DISCUSSION 
These results demonstrate the correlation between the 
upregulation of mRNA for IL-I0 and IFN-'Y, and lympho-
cyte infiltration in the tongue and cervical lymph nodes of 
animals with GVHD. Both cytokine and histopathologic 
changes preceded the clinical manifestation of GVHD. 
Interestingly, involvement of recipient small bowel was not 
clearly defined in this study either before or after the onset 
ofGVHD. 
In the THltrH2 paradigm. cytokines produced by THI 
cells have been associated with rejection and those of TH2 
cells have been favored for tolerance induction. However, 
both sets of THI and TH2 cytokines have been shown to 
appear simultaneously at the site of immune reaction.2 This 
study provides another example that up regulation of THI 
and TH2 cytokines was associated with the development 
and expression of GVHD after small bowel transplantation. 
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